Literature DB >> 22348857

Study of prevalence of epilepsy in children with type 1 diabetes mellitus.

Renuka Ramakrishnan1, Richard Appleton.   

Abstract

PURPOSE: To evaluate the prevalence of epilepsy in children (<16 yrs) with type 1 diabetes.
METHODS: A review of clinical notes and investigations was carried out on all the children with type 1 diabetes who were under follow-up in the Paediatric Diabetes clinic at Alder Hey Children's Hospital in the year 2010.
RESULTS: Of 285 children aged <16 years with type 1 diabetes, six also had epilepsy giving a prevalence of 21/1000. This is approximately six times greater than the prevalence of epilepsy in the general population of children in UK.
CONCLUSION: Epilepsy appears to occur more frequently in children with type 1 diabetes than in the general paediatric population.
Copyright © 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22348857     DOI: 10.1016/j.seizure.2012.01.003

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  9 in total

1.  Epilepsy and behavioral changes, type 1 diabetes mellitus and a high titer of glutamic acid decarboxylase antibodies.

Authors:  Esther Ganelin-Cohen; Dalit Modan-Moses; Rina Hemi; Hannah Kanety; Bruria Ben-Zeev; Christiane S Hampe
Journal:  Pediatr Diabetes       Date:  2015-12-29       Impact factor: 4.866

Review 2.  Diabetes and epilepsy in children and adolescents.

Authors:  M Loredana Marcovecchio; Marianna Immacolata Petrosino; Francesco Chiarelli
Journal:  Curr Diab Rep       Date:  2015-04       Impact factor: 4.810

3.  Type 1 diabetes mellitus and risk of incident epilepsy: a population-based, open-cohort study.

Authors:  George E Dafoulas; Konstantinos A Toulis; Dougall Mccorry; Balachadran Kumarendran; G Neil Thomas; Brian H Willis; Krishna Gokhale; George Gkoutos; Parth Narendran; Krishnarajah Nirantharakumar
Journal:  Diabetologia       Date:  2016-10-31       Impact factor: 10.122

4.  Risk and outcomes of diabetes in patients with epilepsy.

Authors:  Ta-Liang Chen; Chien-Chang Liao; Chun-Cheng Li; Chuen-Chau Chang; Yih-Giun Cherng; Chao-Shun Lin; Chun-Chieh Yeh; Yi-Cheng Chang; Chaur-Jong Hu; Chun-Chuan Shih
Journal:  Sci Rep       Date:  2021-09-23       Impact factor: 4.379

Review 5.  Use of a German longitudinal prescription database (LRx) in pharmacoepidemiology.

Authors:  Hartmut Richter; Silvia Dombrowski; Hajo Hamer; Peyman Hadji; Karel Kostev
Journal:  Ger Med Sci       Date:  2015-08-25

6.  Severe diabetic ketoacidosis complicated by hypocapnic seizure.

Authors:  A Majid; B J Wheeler
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2017-07-07

7.  Carbamazepine, a beta-cell protecting drug, reduces type 1 diabetes incidence in NOD mice.

Authors:  Jason T C Lee; Iryna Shanina; Yung Ning Chu; Marc S Horwitz; James D Johnson
Journal:  Sci Rep       Date:  2018-03-15       Impact factor: 4.379

8.  GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies.

Authors:  Suvi Liimatainen; Jerome Honnorat; Sean J Pittock; Andrew McKeon; Mario Manto; Jared R Radtke; Christiane S Hampe
Journal:  Orphanet J Rare Dis       Date:  2018-04-10       Impact factor: 4.123

9.  Insulin Regulates GABAA Receptor-Mediated Tonic Currents in the Prefrontal Cortex.

Authors:  Saraí Trujeque-Ramos; Diego Castillo-Rolón; Elvira Galarraga; Dagoberto Tapia; Gabina Arenas-López; Stefan Mihailescu; Salvador Hernández-López
Journal:  Front Neurosci       Date:  2018-05-31       Impact factor: 4.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.